UB Spin-Off POP Biotechnologies Reports 100% Protection in Preclinical Trials of H5N1 Avian Flu Vaccine

As H5N1 avian influenza continues its spread across species and continents, a vaccine being developed by University of Buffalo (SUNY) spin-off&nb...

April 22, 2025 | Tuesday | News
Henlius Hosts World R&D Day 2025, Showcasing Innovation and Global Collaboration Under "Collaborate to Create" Theme

 Henlius  celebrated its World R&D Day 2025, under the theme "Collaborate to Create", bringing together senior executives, experts and indust...

April 21, 2025 | Monday | News
POP Biotechnologies' Nanoparticle Vaccine Shows 100% Protection Against H5N1 Avian Influenza in Preclinical Trials

As H5N1 avian influenza continues its spread across species and continents, a vaccine being developed by University of Buffalo (SUNY) spin-off&nb...

April 18, 2025 | Friday | News
Zynext Ventures Invests in Feldan Therapeutics to Advance Next-Gen Intracellular Drug Delivery

Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), announced its investment in Feldan Therapeutics...

April 17, 2025 | Thursday | News
JelloX Biotech and NTUH Report Promising Results for 3D Pathology in Enhancing HER2 Detection in Breast Cancer

 JelloX Biotech Inc., a Taiwan-based startup at the forefront of cancer pathology, announced the preliminary results of a research collaboration ...

April 17, 2025 | Thursday | News
Nikon CeLL and RoosterBio Ink Licensing Deal to Advance Stem Cell and EV Therapies in Japan

Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation has entered into a strategic licensing agreement with RoosterBio, Inc. (RoosterBi...

April 16, 2025 | Wednesday | News
ACRO Biomedical Gets Taiwan MOHW Nod for ABCcolla® Collagen Eye Matrix

ACRO Biomedical Co.,  announced that its ABCcolla® Collagen Ophthalmic Matrix has received regulatory approval from Taiwan's&n...

April 14, 2025 | Monday | News
Lunit and National Cancer Institute Partner to Advance AI-Driven Cancer Research

 Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced a collaboration with the National Cancer Institu...

April 11, 2025 | Friday | News
Seegene Unveils Vision for Next-Gen PCR Automation with CURECA™ System

Seegene Inc., a global leader in molecular diagnostics (MDx), is advancing its vision for innovation in laboratory automation with the development of ...

April 10, 2025 | Thursday | News
Halozyme’s ENHANZE® Technology Powers European Approval of Subcutaneous RYBREVANT® for Advanced NSCLC Treatment

 Halozyme Therapeutics, Inc.announced that Janssen-Cilag International NV, a Johnson & Johnson company, has received European Commission (EC) mark...

April 08, 2025 | Tuesday | News
Innocan Pharma Advances Global Patent Strategy with Divisional Application for Liposome-Based CBD Technology in China

 Innocan Pharma Corporation, a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that a divisional application for it...

April 08, 2025 | Tuesday | News
ABL Bio and GSK Forge Licensing Agreement to Develop Innovative Neurodegenerative Disease Treatments Using BBB Shuttle Platform

ABL Bio Inc. a clinical-stage biotech company developing bispecific antibody technology for immuno-oncology and neurodegenerative diseases, announced a wor...

April 07, 2025 | Monday | News
Mesoblast Confirms U.S. Tariff Exemption for Allogeneic Cellular Products, Including Ryoncil® and Revascor®

Mesoblast, global leader in allogeneic cellular medicines for inflammatory diseases, provided an update on the status of its products in relation to the U....

April 04, 2025 | Friday | News
Thermo Fisher Scientific Launches Krios 5 Cryo-TEM Revolutionizing Structural Biology with Enhanced Throughput and AI Automation

Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Krios™ 5 Cryo-TEM. This next-generati...

April 03, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close